Hyper Insight™ – CTP

Hyper Insight™ Stroke AI

One platform across the stroke pathway — hemorrhage, infarction, aneurysm, perfusion and 3D vascular imaging, on CT and MR. One solution is FDA-cleared today; seven more are in the FDA process. Select any solution for its description, capabilities, and performance evidence.

Hyper Insight™ – CTP

CTPFDA & MFDS in ProgressPre-FDA Access

AI-powered CT perfusion for acute ischemic stroke — resolves ischemic core versus hypoperfused tissue at risk in a single pass, with automated AIF/VOF detection and threshold-based mismatch volumetrics.

Capabilities
  • Automated AIF / VOF detection — anchors arterial input within the MCA territory
  • Four quantitative maps — CBF, CBV, MTT, Tmax
  • Threshold-graded core, penumbra and mismatch volumes, mismatch ratio and Hypoperfusion Intensity Ratio (HIR)
  • Under 2-minute processing
  • Motion correction & modern deconvolution
CTPAISLocalizationROI VisualizationAutomated QuantificationsMismatch RatioHIRMotion Correction9 Reports
CTP 1CTP 2CTP 3CTP 4CTP 5CTP 6CTP 7CTP 8CTP 9
Click to zoom
Performance & evidence

Automated AIF / VOF detection — arterial input anchored within the MCA territory, with a 0.96% mis-selection rate (7/731). Under 2-minute processing — maps and volumetrics returned inside the door-to-decision window. Volumetric agreement with a widely-adopted FDA-cleared CTP tool: CBF<30% volume Pearson r=0.94 · Tmax>6s volume Pearson r=0.93.

⚠ Latest internal validation results

What it means clinically
  • Automates the most technically demanding step in CT perfusion analysis — arterial input function selection — with a mis-selection rate of 0.96%.
  • Time to result under 2 minutes from acquisition: four maps plus core, penumbra, mismatch volume, mismatch ratio and HIR.
  • Automatic rigid-body motion correction.